Stockscreener 앱 받기
20.52
0.73%
-0.15
Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스
First Week of March 20th Options Trading For Syndax Pharmaceuticals (SNDX) - Nasdaq
Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After Last Year’s 62.5% Share Price Gain? - Yahoo Finance
Trading Systems Reacting to (SNDX) Volatility - Stock Traders Daily
Rate Hike: Will Syndax Pharmaceuticals Inc benefit from green energy policiesWeekly Profit Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Insider Buy: Will Syndax Pharmaceuticals Inc stock recover faster than peersJuly 2025 PreEarnings & AI Driven Stock Reports - Bộ Nội Vụ
Assessing Syndax Pharmaceuticals (SNDX) Valuation After Expanded Revuforj Access And Recent Leukemia Progress - Sahm
Market Trends: Can Syndax Pharmaceuticals Inc disrupt its industryPortfolio Return Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Star Tribune - FinancialContent
Bearish Setup: Can Syndax Pharmaceuticals Inc disrupt its industryGDP Growth & Real-Time Sentiment Analysis - baoquankhu1.vn
Wall Street Zen Downgrades Syndax Pharmaceuticals (NASDAQ:SNDX) to Sell - MarketBeat
Market Trends: Will Syndax Pharmaceuticals Inc. (1T3) stock benefit from Fed rate cutsTrade Risk Report & Expert Verified Movement Alerts - Улправда
Why Syndax Pharmaceuticals Inc. stock could outperform in 2025Recession Risk & Real-Time Buy Zone Alerts - Улправда
Will Syndax Pharmaceuticals Inc. (1T3) stock benefit from Fed rate cutsJuly 2025 Gainers & Real-Time Chart Pattern Alerts - Улправда
How strong is Syndax Pharmaceuticals Inc. stock revenue growthDollar Strength & High Win Rate Trade Alerts - Улправда
Will Syndax Pharmaceuticals Inc. stock outperform Nasdaq indexQuarterly Investment Review & Real-Time Stock Entry Alerts - ulpravda.ru
Tech Rally: Can Syndax Pharmaceuticals Inc. stock beat analyst upgradesPortfolio Risk Summary & Low Risk High Win Rate Picks - Улправда
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 9.8% HigherShould You Buy? - MarketBeat
Syndax, World Orphan Drug Alliance Collaborate to Expand Access to Revuforj for Leukemia - marketscreener.com
Syndax (SNDX) Expands Global Access to Revuforj with New Partner - GuruFocus
Syndax Pharmaceuticals and World Orphan Drug Alliance Announce Collaboration to Expand Access to Revuforj® in Emerging Markets - Quiver Quantitative
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 6.5%What's Next? - MarketBeat
Syndax Pharmaceuticals CEO to Present at 44th Annual J.P. Morgan Healthcare Conference | SNDX Stock News - Quiver Quantitative
Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Published on: 2026-01-06 01:29:59 - moha.gov.vn
How Syndax Pharmaceuticals Inc. (SNDX) Affects Rotational Strategy Timing - Stock Traders Daily
Syndax Pharmaceuticals (NASDAQ:SNDX) Upgraded at Wall Street Zen - MarketBeat
Syndax Pharmaceuticals Q3 2025 Earnings Preview - MSN
Commit To Buy Syndax Pharmaceuticals At $13, Earn 21.5% Using Options - Nasdaq
Is Syndax Pharmaceuticals (NASDAQ:SNDX) Using Debt Sensibly? - 富途牛牛
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 1-Year HighTime to Buy? - MarketBeat
(SNDX) Risk Channels and Responsive Allocation - Stock Traders Daily
SNDX (Syndax Pharmaceuticals) EV-to-OCF : -4.35 (As of Dec. 21, 2025) - GuruFocus
Syndax Pharmaceuticals (STU:1T3) EV-to-OCF : -4.13 (As of Dec. 21, 2025) - GuruFocus
Syndax Pharmaceuticals modernizes bylaws for electronic share issuance - MSN
How Syndax Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Volatility Report & AI Enhanced Trading Alerts - Bölüm Sonu Canavarı
Syndax Pharmaceuticals Modernizes Bylaws for Electronic Share Issuance - TipRanks
Published on: 2025-12-19 14:41:17 - DonanımHaber
Assenagon Asset Management S.A. Sells 255,848 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Will Syndax Pharmaceuticals Inc. stock beat EPS estimates2025 Market Overview & Community Trade Idea Sharing - ulpravda.ru
Syndax Pharmaceuticals (STU:1T3) EV-to-OCF : -3.99 (As of Dec. 19, 2025) - GuruFocus
How currency fluctuations impact Syndax Pharmaceuticals Inc. stock2025 Market Sentiment & Safe Capital Allocation Plans - ulpravda.ru
Syndax Pharma: Continuing Execution In AML (NASDAQ:SNDX) - Seeking Alpha
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 52-Week HighWhat's Next? - MarketBeat
Can Revuforj’s Awards Momentum Redefine Syndax Pharmaceuticals’ (SNDX) Precision Oncology Investment Narrative? - Sahm
Syndax Pharmaceuticals stock hits 52-week high at $21.27 By Investing.com - Investing.com Canada
Hudson Bay Capital Management LP Has $4.15 Million Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals Earnings Notes - Trefis
Syndax Pharmaceuticals (FRA:1T3) OCF Margin % : -153.77% (As of Sep. 2025) - GuruFocus
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Syndax Pharmaceuticals' Revuforj® Recognized as Best New Drug at 2025 Scrip Awards - Quiver Quantitative
Syndax (Nasdaq: SNDX) wins Scrip 2025 Best New Drug for FDA-approved Revuforj - Stock Titan
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025 - GlobeNewswire
(SNDX) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Is Syndax Pharmaceuticals Inc 1T3 a good long term investmentCandlestick Pattern Analysis & Rapid Portfolio Expansion - earlytimes.in
Jump Financial LLC Makes New $3.57 Million Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week HighHere's Why - MarketBeat
4.73%
0.92%
자본화:
|
볼륨(24시간):